Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial

Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
doi: https://doi.org/10.1101/2021.05.14.21256900

Article Information

doi 
https://doi.org/10.1101/2021.05.14.21256900
History 
  • May 14, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Prof. Dr. Suresh B. Patankar*,1,
  2. Dr. Hrishikesh Rangnekar2,
  3. Dr. Kalpana Joshi3,
  4. Dr. Kishor Suryawanshi4,
  5. Dr. Pravin Soni4,
  6. Dr. Anupama Gorde5,
  7. Dr. Tejas Shah6,
  8. Mr. Sagar Patankar1,
  9. Dr. Diwakar Jha8 and
  10. Dr. Rajesh Raje1
  1. 1AMAI Charitable Trust, Pune
  2. 2Quest Clinical Services, Pune
  3. 3Dept. of Biotechnology, Sinhgad College of Engineering, Pune
  4. 4YCM Hospital, Pune
  5. 5Sinhgad Institute of Dental Sciences, Pune
  6. 6Krsnaa Diagnostics Pvt. Ltd. Pune
  7. 8SHRIPAD Medisearch Pvt. Ltd., Pune
  1. ↵*Corresponding Author: sureshpatankarace{at}gmail.com
Back to top
Posted May 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Efficacy and Safety of Polyherbal formulation as an add-on to the standard of care in mild to moderate COVID-19: A randomized, double-blind, placebo-controlled trial
Suresh B. Patankar, Hrishikesh Rangnekar, Kalpana Joshi, Kishor Suryawanshi, Pravin Soni, Anupama Gorde, Tejas Shah, Sagar Patankar, Diwakar Jha, Rajesh Raje
medRxiv 2021.05.14.21256900; doi: https://doi.org/10.1101/2021.05.14.21256900
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area